BAX is expected to report earnings to rise 5.81% to 84 cents per share on January 30
Q4'24
Est.
$0.85
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.02
The last earnings report on November 08 showed earnings per share of 80 cents, beating the estimate of 77 cents. With 1.86M shares outstanding, the current market capitalization sits at 21.77B.
a provider of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices